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1. Introduction 
Pseudomonas testosteroni As +, -3-oxosteroid iso- 
merase (EC: 5.3.3.1) [l] is a dimer of appiox. 27 000 
daltons [2], composed of two polypeptide chains of 
of identical molecular weight [2-41 and primary 
sequence [S] . In this work, the binding of three com- 
petitive inhibitors to isomerase has been studied by 
different techniques. The results obtained by equilib- 
rium dialysis and by measurements of the ultraviolet 
fluorescence of the protein have been compared. The 
dissociation constant for each of the three ligands as 
measured by these two techniques and by kinetic 
studies are in very good agreement. Both approaches 
agree in assigning only a single binding site per iso- 
merase dimer; a second weaker binding site, if any 
exists, could not be evidenced under the present 
experimental conditions. Such an apparent reactivity 
of only half of the enzyme sites has been described 
with different intracellular oligomeric enzymes involv- 
ed in metabolic pathways (e.g. alkaline phosphatase 
from E. coU), and the functional evolutionary interest 
of the interdependence of the subunits in the catalytic 
process has been discussed [6,7]. As far as we know, 
this ‘half-of-the-sites’ reactivity is the first one observed 
with an enzyme involved in steroid hormone metabo- 
lism. This finding of a single binding site for steroids 
which are either substrate analogs or products, opens 
the question of the functional unequality of the two 
potential binding sites ia the isomerase dimer, and 
consequently of a possible regulatory mechanism 
applicable to such an enzyme under physiological 
conditions. 
2. Experimental procedure 
2.1. Isomerase 
Isomerase was purified and crystallized as usually 
[S-lo]. Its homogeneity was checked by polyacryl- 
amide gel electrophoresis and by its ultraviolet 
characteristic spectrum. Pure isomerase has a specific 
activity of about 55 000 units/mg, using the new 
q.‘,z value at 280 nm of 0.328 f 0.004 [2]. One 
unit of enzyme isomerizes 1 pmol of A5-androstene- 
3,17-dione per min under standard conditions [ 111. 
2.2. Steroids and measurements of radioactivity 
Labelled steroids: [6,7-3H]estradiol (spec. act.: 
43 Ci/mmol), was purchased from N.E.N. (Boston, 
Mass.), [4-14C] 19nortestosterone (spec. act.: 40 Ci/ 
mmol) was a C.E.A. (Saclay, France) product. Purity 
was assessed by thin-layer chromatography. 
Radioactivity was measured with a Packard liquid 
scintillation counter in 10 ml Bray’s solution (efficiency 
16-20%), or in 10 ml of 4 g Omnifluor (N.E.N.)/liter 
toluene (efficiency 40%). 
Unlabelled steroids were given by Roussel-Uclaf and 
used without any further purification. 
2.3. Chemicals 
The potassium phosphate buffer was made with 
Merck products. Methanol and ethanol were from 
Prolabo (‘ultrapur’) and dioxan was from Merck 
(Uvasol for spectroscopy). 
2.4. Equilibrium dialysis 
Dialysis tubing (Visking tubing 8/ 100 ft, Union 
Carbide Corp.) was successively boiled with sodium 
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carbonate, then slowly cooled with EDTA solution 
and washed extensively with distilled water. Dialyses 
were performed at 4°C. One ml aliquots of isomerase 
solution in 0.03 M potassium phosphate buffer, pH 7.0, 
containing 1% v/v of methanol were dialyzed with 
magnetic stirring against 15 ml of the same medium, 
radioactive 19nortestosterone or estradiol being 
introduced outside the tubing. After 20 hours (16 h 
is the time necessary to reach equilibrium), the radio- 
activity inside and outside the tubing was measured 
and steroid concentrations were calculated. The 
unbound steroid concentration (U) is equal to the 
steroid concentration outside the tubing; the bound 
steroid concentration (B) is obtained from the differ- 
ence between the total steroid concentration (T) 
inside the tubing and (U). The equilibrium dissocia- 
tion constant (Kr-,) and the concentration of binding 
sites (N) were determined according to Scatchard [ 121. 
2.5. Fluorescence titration by two competitive 
inhibitors 
The titration was performed with a Fica 55 record- 
ing differential spectrofluorimeter which gives absolute 
fluorescence spectra. Fluorescence intensities were 
expressed in arbitrary units and no correction for self 
absorption of the incident light was necessary since 
absorbancy at the excitation wavelength was < 0.09. 
The fluorescence emission spectrum of isomerase, 
a protein devoided of tryptophan residues, has a 
maximum at 305 nm (maximum excitation wavelength 
275 nm). The tyrosine fluorescence intensity at 305 nm 
of an isomerase solution is quenched by the stepwise 
addition of steroid ligands which are competitive 
inhibitors: 19nortestosterone (A4-androsten-3-one- 
17p-01) and equilenin (A’~~~5~6~8-estra-penten-3,17-diol); 
since these steroids do not fluoresce at 305 nm when 
excited at 275 nm, it is possible to follow the iso- 
merase-steroid interaction by a selective fluorescence 
quenching technique [ 131. 
Isomerase titrations have been performed with 
silica cells containing 1.5 ml of an isomerase solution 
in 0.03 M potassium phosphate buffer, pH 7 at 26°C. 
The isomerase concentration range varied from 1.2 PM 
to 7.3 PM, where linearity between fluorescence and 
protein concentration is observed. After each addition 
of steroid dissolved in dioxan or methanol, the 
fluorescence intensity at 305 nm is measured when 
exciting the protein at 275 nm. Corrections for 
protein dilution were made from blank titrations with 
methanol or dioxan. 
From the experimental data, the number of binding 
sites (N) and the dissociation constant (K,) were 
determined according to graphical representations 
derived from the law of mass action, namely the 
Scatchard representation [ 121 and plots based on the 
equation T/E, = N t K,/E, where T is the final 
ligand concentration in the assay medium, EL and 
E, the concentration of liganded and free protein 
respectively. These two representations assume for 
isomerase one single molecular species, N independent 
binding sites equivalent with respect to affinity, and 
interaction of the ligand at each site occurring with 
the same fluorescence quenching. 
3. Results and discussion 
3.1. Dialysis equilibrium studies 
Isomerase (1 to 4 PM) was exposed to different 
concentrations of radioactive 19nortestosterone or 
estradiol which are competitive inhibitors of the 
isomerization reaction. The enzyme is not denatured 
during the time necessary for dialysis experiments, as 
checked by the measure of the enzymatic activities 
before and after dialysis. Fig.1 (curves a and b) shows 
the Scatchard plots (obtained in the presence of 1% 
v/v of methanol), giving for 19nortestosterone a K, 
Fig.1. Scatchard plots of the binding of 19-nortestosterone 
(curve a) and estradiol (curve b) to isomerase 1.0 PM, as 
obtained by equilibrium dialysis experiments. Dialyses were 
performed in 0.03 M potassium phosphate buffer, pH 7.0, 
in 1.6% v/v of ethanol at 4°C. Results are Kf = 1.7 PM and 
N = 0.98 for 19nortestosterone, and Kf = 0.85 MM and 
N = 1.08 for equilenin. 
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Fig.2. Excitation and emission spectra of isomerase (3.8 @M) 
and equilenin (5.4 MM) in 0.03 M potassium phosphate 
buffer, pH 7.0. Curves a and b are the excitation and emission 
spectra of isomerase. Curve c is the excitation spectrum of 
equilenin, d and e are emission spectra of equilenin excited 
at 275 nm and 335 nm, respectively. 
value of 1.7 /.LM and a N value of 0.98 and for estradiol 
a Kl value of 0.85 PM and a N of 1.08. These results 
with two different competitive inhibitors therefore 
suggest one binding site per isomerase dimer. 
3.2. Fluorescence studies 
Fig.2, curves a and b, depicts the fluorescence 
excitation and emission spectra of an isomerase solu- 
tion in 0.03 M potassium phosphate buffer, pH 7. 
The emission spectrum of isomerase is characterized 
by two neighbour peaks centered at 298 nm and 
305 nm. 
Fig.2, curve c, shows the excitation spectrum of 
equilenin in the same medium but containing 2% v/v 
of dioxan; it displays two peaks located at 265 nm and 
335 nm. Curves d and e show the emission spectra of 
free equilenin when excited at 275 nm and 335 nm 
respectively. The same maximum is observed and the 
fluorescence intensity of the trailing part of the 
emission spectrum at 305 nm is negligible. 
Fig.3 represents the differences emission spectra 
of a reference isomerase solution (7.1 PM), in 0.03 M 
potassium phosphate buffer, pH 7, against the same 
solution of isomerase with increasing equilenin con- 
t 
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Fig.3. Fluorimetric difference spectra of isomerase and 
isomerase with increasing equilenin concentrations. The 
reference cell contains isomerase (7.1 PM) in 0.03 M 
potassium phosphate buffer, pH 7.0. The titration cell 
contains the same isomerase concentration (7.1 MM) in the 
same medium, with successively different equilenin concen- 
trations: 1.80~M,3.58~M,5.35~M,7.1~Mand 10.6rM. 
centrations. Fluorescence modifications are observed 
both in the protein and equilenin region. In the 
equilenin fluorescence region, two emission peaks 
are observed at 365 nm and 405 nm at low equilenin 
concentrations. The last one (405 nm) can be related 
to the complex formation. At higher equilenin con- 
centrations, the percentage of free equilenin with 
respect to the complex increases and the emission 
peak at 365 nm previously described overlaps the 
peak at 405 nm. In the protein fluorescence region, 
the decrease of fluorescence intensity at 305 nm 
(fig.3) corresponds to the quenching of the emission 
of isomerase when interacting with equilenin. 
Fig.4 depicts the dependence of fluorescence 
quenching of isomerase (3.8 PM) as a function of the 
final ligand concentration. 
The saturation curves with 19nortestosterone 
(llg.4, curve a) or equilenin (curve b) may be analyzed 
to yield the binding constant i.e. N and K, [ 131. For 
this purpose, it is necessary to relate the observed 
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Fig.4. Fluorescence saturation curves of isomerase (3.8 r&i) 
with 19nortestosterone (a) and equilenin (b). Experiments 
were performed in 0.03 M potassium phosphate buffer, 
pH 7.0 and 26”C, at emission wavelength 305 nm (excitation 
wavelength 275 nm). Qm for 19-nortestosterone is equal to 
10 arbitrary fluorescence units and to 14.2 arbitrary fluores- 
cence units for equilenin. 
degree of quenching either to the number of moles 
of steroid bound per mole of isomerase dimer for 
Scatchard plots [ 121 or to the concentration of 
liganded 
protein (EL) for graphs based on ?-- = N + - KD 
EL EF 
The EL calculation requires the determination of Qn,, 
which corresponds to the maximum fluorescence 
decrease of a I.~M isomerase solution occurring when 
isomerase is totally complexed by the steroid. 
Experimentally, Q, is obtained from the difference 
between the fluorescence intensity I, of a I.IM free 
isomerase solution (I, = 20 fluorescence arbitrary 
units) and the residual fluorescence intensity I, when 
this PM protein solution is saturated by the ligand 
(Q, = I, - I,). This I, value was extrapolated from 
experimental data obtained at ligand concentrations 
T equal or higher than 9 times the protein concentra- 
tion. By plotting l/I, as a function of l/T (If are the 
fluorescent intensities at different ligand concentra- 
tions), a straight line is obtained: its intercept on the 
ordinate axis gives I,. Thus, to any quenched 
fluorescence intensity (Q = I, - If) of the saturation 
curve at a ligand concentration (T), corresponds a con- 
centration EL equal to $ and EE is equal to ET - EL 
(b being the enzyme cokentration). By plotting T/E, 
as a function of 1 /EF, a straight line was obtained, 
with a slope K, and an intercept on the ordinate 
equal to N. The average Q, values (expressed in 
arbitrary fluorescence units per PM isomerase solution) 
are 15 and 10 for 19nortestosterone and equilenin 
respectively. 
For Scatchard plots, the ‘QO’ value which 
corresponds to the quenching efficiency of a PM bound 
steroid solution, is experimentally determined from 
the plateau value obtained by plotting the quenched 
intensities divided by ligand concentration in PM as a 
function of protein concentration (using the lowest 
steroid concentrations giving a fluorescence quenching 
response) (fig.5). The Q, values (15 for equilenin and 
10 for 19nortestosterone) were obtained for the 
highest possible protein concentrations 7 FM (since at 
higher concentration, there is no linearity between 
fluorescence intensity and protein concentration). 
Thus, the concentration of bound steroid (B) at any 
fluorescence quenching intensity (Q) of the satura- 
tion curve is given by the ratio Q/Q,. The unbound 
steroid concentration (U) was obtained from the 
difference between the total ligand concentration 
(T) and (B). The slope of the plot (B)/(U) versus (B) 
gave l/KD and the intercept on abscissa NE,, 
E, being the protein molar concentration and N the 
number of binding sites per isomerase dimer. 
Fig.6a represents the Scatchard plot and fig.6b 
the graph T/EL versus l/E, obtained with 1.1 PM of 
I 
1 ._ 
Fig.5 Determination of X&O’ value of equilenin. Plot of the 
quenched intensity per JIM of ligand as a function of protein 
concentration. 
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Fig.6. Spectrofluorimetric equilenin isomerase titration. 
Isomerase concentration was 1.1 PM. Excitation and emission 
wavelength were 275 nm and 307 nm, respectively. 
(a) Scatchard plot. Data were plotted according to equation 
B/U = NET/KD - B/KD. (b) Data were plotted according to 
equation T/EL = KI/EF + N. Experiments were performed 
in 0.03 M potassium phosphate buffer, pH 7.0 and at 26°C. 
The mean KD and N values obtained are 1 PM and 1 binding 
site respectively. 
isomerase (as titrated with equilenin). The two 
different plots gave a N value of 1 .O and a KD of 
1 .O FM. 
The fluorescence results at different isomerase 
concentrations are summarized on table 1. As seen, 
the binding constants N and KD are very similar 
whatever the protein concentration (1-7 PM) and the 
graphical representations. Again one binding site per 
dimer was obtained, and KD were 1 PM and 2 MM for 
equilenin and 19nortestosterone, respectively. 
Finally the fluorimetric and dialysis equilibrium 
experiments using 19nortestosterone and two 
estrogens which are competitive inhibitors of the 
isomerization reaction, indicate unambiguously the 
existence of a single binding site per isomerase dimer 
(table 2). The 2 methods give a very close KD value 
for 19nortestosterone. The low solubility of steroids 
in the aqueous medium do not allow to increase 
sufficiently the hormone concentration in order to 
demonstrate another, but weaker, binding site. On 
the basis of the identity of the 2 polypeptidic chains 
Table 1 
Fluorimetric determination of binding constants KD and 
N of 19nortestosterone and equilenin 
concentrations 
19nortestosterone Equilenin Medium 
KD N KD N Cosolvent % 
(PM) (PM) v/v 
1.2 2.0 1.0a 1.1 0.9; Dx 0 to 4 
2.3 l.Ob 1.0 0.9b 
2.7 1.2 l.Oa Dx 0 to 4 
1.3 l.Ob 
3.8 1.8 1.0a 1.0 l.Oa Dx 0 to 4 
1.5 l.Ob 1.0 l.Ob 
7.1 0.6 1.0a 
1.1 l.Ob 
MeOH 0 to 4 
7.3 1.5 0.8a 
2.1 0.9b 
MeOH 0 to 4 
Dx: dioxan; MeOH: methanol. 
a from Scatchard plot. 
b from graph T = N + -. 
KD 
EL EF 
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Table 2 
Binding parameters of 19nortestosterone and equilenin 
as determined by different methods 
L&and KI KD (rM) N 
E.D F E.D F 
19-Nortestosterone 3.2 1.7 2.0 1 1 
Equilenin 1.5 - 1 - 1 
Februari 1976 
Kl: Inhibition constant as determined by kinetic study using A5-androstene- 
3,17dione as substrate in 0.03 M pOtdSSiUm phosphate buffer in 1.6% v/v of 
methanol. 
KD: dissociation constant as determined by Equilibrium dialysis (E.D) and 
fluorescence (F). 
N: number of binding sites. 
of isomerase, one may suggest hat the ‘half-of-the- 
sites’ reactivity may imply a negative homotropic 
cooperativity in ligand binding. 
Additional data will be reported [ 141 supporting 
the possibility of the flip-flop mechanism [ 5,6,15] for 
the isomerization process. They could shed some 
light on the apparently antinomic properties of the 
enzyme: Michaelian behaviour and ‘half-of-the-sites’ 
reactivity. 
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